A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure

Summary

The main aim of this study is to check the safety of TAK-536. This study will take place in Japan. At the first visit, the study doctor will check if each child can take part. For those who can take part, each participant will have a check-up by the study doctor. After this, each participant will take placebo. This might take 2 weeks. After this, parents or the caregivers of each participant will be given sachets that contain granules of TAK-536 to give to that participant. The participants will take the TAK-536 granules once a day for 52 weeks. After treatment has finished, participants will visit the study clinic for a final check-up.

Timeline

Start

2021-05-17

Primary completion

2023-12-28

Completion

2023-12-28

Drugs

Indications